This week, there are 11 drugs in the patent and exclusivity list. They are: - BAUSCH AND LOMB INC's XIIDRA, containing active ingredient LIFITEGRAST - FRESENIUS KABI USA LLC's OMEGAVEN, containing active ingredient FISH OIL TRIGLYCERIDES - MYLAN SPECIALTY LP's TOBI PODHALER, containing active ingredient TOBRAMYCIN - ASTRAZENECA LP's SYMBICORT, containing active ingredient BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE - ASTRAZENECA AB's BYETTA, containing active ingredient EXENATIDE SYNTHETIC - HOFFMANN-LA ROCHE INC's ALECENSA, containing active ingredient ALECTINIB HYDROCHLORIDE - HOFFMANN LA ROCHE INC's ZELBORAF, containing active ingredient VEMURAFENIB - GISKIT PHARMA BV's EXEM FOAM KIT, containing active ingredient AIR POLYMER-TYPE A - MERCK SHARP AND DOHME CORP's PREVYMIS, containing active ingredient LETERMOVIR - MERCK SHARP AND DOHME LLC's PREVYMIS, containing active ingredient LETERMOVIR - BRISTOL MYERS SQUIBB CO's SPRYCEL, containing active ingredient DASATINIB Read More